Extrawell Pharmaceutical Holdings Ltd. has announced a board meeting scheduled for Monday, 30 June 2025. During this meeting, the board will approve the annual results of the company and its subsidiaries for the year ended 31 March 2025 and address other business matters.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.